Sanofi SA

SAN: XPAR (FRA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|&gLOCK|mJ#%&LOCK|DH>!zx

Sanofi: Reassessing Our Moat Rating for This Leader in Immunology, Vaccines, and Rare Diseases

We have taken a fresh look at our economic moat rating for Sanofi after reassessing our outlook for the company's returns on invested capital over the next 10 years.

Sponsor Center